» Articles » PMID: 15482339

Overexpression of Extracellular Signal-regulated Protein Kinase and Its Correlation with Proliferation in Human Hepatocellular Carcinoma

Overview
Journal Liver Int
Specialty Gastroenterology
Date 2004 Oct 16
PMID 15482339
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Dysregulation of cell proliferation is one of the most important features of human cancers including hepatocellular carcinoma (HCC). However, the molecular basis underlying the proliferation of HCC has not been fully clarified. Because a previous study reported that overexpression of extracellular signal-regulated protein kinase (ERK), which transduces extracellular growth stimuli to the nuclei, was frequently observed in several human cancers, this study was performed to analyze the expression of ERK in human HCC and its correlation with HCC proliferation.

Methods: Twenty-four paired samples of primary HCCs and corresponding noncancerous liver tissues, and six samples of histologically normal liver tissue were obtained from surgically resected materials. The expression of ERK was examined by immunoblotting and immunohistochemical analysis. Proliferative activity of each HCC was examined by immunohistochemical demonstration of proliferative cell nuclear antigen (PCNA).

Results: The ERK1 and ERK2 expression in HCCs was significantly higher than that in noncancerous liver tissues, and the ERK1 expression in noncancerous liver tissues from patients with HCC was higher than that in tissue from normal liver. Immunohistochemical examination revealed enhanced accumulation of ERK1 in the nuclei of HCC cells. Regression analysis revealed a significant correlation between ERK expression and PCNA labeling index in HCC.

Conclusions: Our findings suggest that ERK overexpression contributes to the proliferation of HCC.

Citing Articles

A Comprehensive Narrative Review on the History, Current Landscape, and Future Directions of Hepatocellular Carcinoma (HCC) Systemic Therapy.

Lazzaro A, Hartshorn K Cancers (Basel). 2023; 15(9).

PMID: 37173972 PMC: 10177076. DOI: 10.3390/cancers15092506.


microRNA-203 functions as a natural Ras inhibitor in hepatocellular carcinoma.

Guo J, Li L, Deng N, Xu Y, Wang G, Luo H Am J Cancer Res. 2023; 13(4):1295-1309.

PMID: 37168327 PMC: 10164818.


SPRED2: A Novel Regulator of Epithelial-Mesenchymal Transition and Stemness in Hepatocellular Carcinoma Cells.

Gao T, Yang X, Fujisawa M, Ohara T, Wang T, Tomonobu N Int J Mol Sci. 2023; 24(5).

PMID: 36902429 PMC: 10003366. DOI: 10.3390/ijms24054996.


ARID1A Is a Prognostic Biomarker and Associated with Immune Infiltrates in Hepatocellular Carcinoma.

Feng Y, Tang X, Li C, Su Y, Wang X, Li N Can J Gastroenterol Hepatol. 2022; 2022:3163955.

PMID: 35028302 PMC: 8752298. DOI: 10.1155/2022/3163955.


The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma.

Qin S, Mao Y, Chen X, Xiao J, Qin Y, Zhao L Int J Biol Sci. 2021; 17(12):3059-3079.

PMID: 34421350 PMC: 8375232. DOI: 10.7150/ijbs.62767.